Local Coverage Decisions (LCDs)
- June 2020: Future Effective Oxygen and Oxygen Equipment LCD (DL33797)
- Dec. 2019: WPS Wound Care LCD
- Nov. 2018: Noridian policy article "Use of Amniotic Membrane Derived Skin Substitutes”
- April 2018: WPS Wound Care Coding Companion for Wound Care L37228 (A55909)
- April 2018: WPS Future Local Coverage Determination - Wound Care (L37228)
- Sept. 2017: Novitas policy on Wound Care (L35125) - Final
- June 2017: DMEMAC Surgical Dressing LCD (L33831) and policy article – Final
- May 2017: DMEMACs LCD on Negative Pressure Wound Therapy Pumps (L33821) – Final
- March 2017: DMEMACs coverage updates with a revised NPWT policy that included the new NPUAP staging terminology. See LCD and policy article
- March 2017: Wisconsin Physicians Service Insurance Corporation (WPS) draft LCD on wound care (DL37228)
- Feb. 2017: Novitas Solutions draft LCD on treatment of varicose veins of the lower extremities (DL34924)
- Jan. 2017: First Coast Service Option draft LCD on wound care (DL37166)
- Jan. 2017: Novitas Solutions draft LCD on wound care (DL35125)
National Coverage Decisions (NCDs)
- May 2017: CMS Decision Memo Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)
- April 2017: CMS Decision Memo for Hyperbaric Oxygen (HBO) Therapy
CMS Regulations
Prospective Payment System (PPS) Regulations - proposed and final - August 2020: Proposed Rule - CY 201 Hospital Outpatient PPS (see CMS fact sheet)
- August 2020: Proposed Rule - CY 2021 Physician Fee Schedule
- May 2020: Proposed Rule - CY 2021 Hospital Inpatient PPS for Acute Care and Long-Term Care Hospitals
- April 2020: Proposed Rule - CY 2021 PPS for Skilled Nursing Facilities
- November 2019: Final Rule - CY 2020 End-Stage Renal Disease/Durable Medical Equipment
- November 2019: Final Rule - CY 2020 Hospital Outpatient Prospective Payment System
- November 2019: Final Rule - CY 2020 Physician Fee Schedule
- October 2019: Final Rule - CY 2020 Home Health Prospective Payment System
- August 2019: Final Rule - CY 2020 Medicare Hospital Inpatient Prospective Payment System (IPPS)
Quality Payment Program and MACRA implementation regulations - proposed and final
- Nov. 2017: Quality Physician Payment Program
- June 2017: CMS CY 2018 Updates to MACRA’s Quality Payment Program and fact sheet
- Oct. 2016: Quality Payment Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models
- Dec. 2016: CMS updates to Patient Relationship Categories and Codes
- May 2016: CMS proposed Patient Relationship Categories and Codes
- May 2016: Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs) in Medicare Fee-for-Service (CMS-5517-P)
- Nov. 2016: Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models
Miscellaneous - CMS
- June 2020: CMS creates Office of Burden Reduction and Health Informatics - an outgrowth of the agency’s Patients over Paperwork Initiative
- May 2019: CMS strategy to foster innovation for transformative medical technologies (includes allowing medical device manufacturers to submit HCPCS code applications twice a year rather than once a year)
- Oct. 2018: Changes to the Medicare Program Integrity Manual - Local Coverage Determinations (see accompanying MedLearn Matters)
- May 2018: Pre-Claim Review Demonstration for Home Health Services
- Sept. 2017: CMS Request for Information regarding the direction of the Center for Medicare and Medicaid Innovation Center (CMMI)
- July 2017: CMS Withdrawal of Part B Drug Payment Model Proposal
PDAC, MEDCAC, HCPCS Workgroups
- Nov. 2018: Changes to the HCPCS Coding Process for 2019
- Nov. 2018: CMS Level II HCPCS Coding Decisions for the 2018-2019 Coding Cycle
- Nov. 2017: CMS release of the 2018 Healthcare Common Procedure Coding System (HCPCS) code set
FDA
- Nov. 2017: Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff
- Aug. 2017: Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices – Guidance for industry and FDA staff
- Aug. 2016 - FDA’s General & Plastic Surgery Devices Panel public meeting notice regarding the classification of antimicrobial wound care products as Class II with special controls
- Dec. 2015: Minimal Manipulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and FDA Staff
- Dec. 2015: Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products: Draft Guidance for Industry and FDA Staff
AHRQ
- February 2020: AHRQ final technology brief: Skin Substitutes for Treating Chronic Wounds
- June 2019: AHRQ re-opening of and update to Skin Substitutes technical brief: "Disposition of Submissions of Supplemental Evidence and Data for Systematic Reviews”
- January 2018: AHRQ draft technical brief Skin Substitutes for Treating Chronic Wounds
- April 2017: AHRQ technology assessment report Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)
Medicare Payment Advisory Commission (MEDPAC)
- MedPAC reports to Congress
- MedPAC public meetings
Legislation
- Oct. 2017: H.R. 2445 DMEPOS Access & Transparency Act of 2017
- Aug. 2017: H.R. 3635 Local Coverage Determination Clarification Act of 2018
- March 2017: S.794 Local Coverage Determination Clarification Act of 2018
- March 2017: H.R.1542 - HELLPP Act
